The fund specializes in investing in medical technologies (equipment and medical systems), in biotechnology, and agrotechnology. Most of the companies in the list are therefore in these fields.
Mindsense Biosystems* has developed a revolutionary kit for biological monitoring of psychological disorders through a blood test, in order to diagnose the disorder (depression, mania, panic and schizophrenia). Mindsense's technology will revolutionize diagnosis of psychological disorders, and will assist in determining the appropriate dosage for patients, and monitoring treatment.
CBD* has developed, together with leading international research institutes, a broad spectrum basic technology based on genetic engineering processes, which significantly accelerates growth in trees and other agricultural crops. Moreover, the technology enables state-of-the-art developments in the manufacture of drugs, identification of food and drinking water pollutants, elimination of industrial pollutants and more.
ASI* has technology that enables molecular diagnostics through color imaging. The system this Israeli company has developed represents a significant breakthrough in diagnostics.
Karmel Medical* has developed a family of products capable of diagnosing, analyzing and graphically registering breathing sounds of people suffering from chronic lung diseases such as asthma etc. In addition, the system is capable of monitoring patients in critical condition in real time. The system developed by the company provides doctors with objective information regarding the patient's situation, while being able to provide early recognition of changes in breathing. The system is designed for hospitals, emergency care units, operating rooms and clinics.
Proneuron* State-of-the-art technology for the regeneration of nerves in the central nervous system, and the treatment of diseases. Using the method the company developed, partial recovery of an injured vertebrae in rats was accomplished, thereby leading to partial refunctioning of movement lost as a result of the injury to the vertebrae.
Compugen Hardware and software for bioinformatics analysis.
Angiosonics Ultrasound for the treatment of blockages in heart arteries deriving from blood clots.
Oridion Instrument for analyzing level of gas and carbon dioxide in breath.
XTL Creating human disease models in animals for drug testing.
Published by Israel's Business Arena December 30, 1998